Morgan Stanley Chimerix Inc Transaction History

Morgan Stanley

$1.27 Trillion
Q2 2024

A detailed history of Morgan Stanley transactions in Chimerix Inc stock. As of the latest transaction made, Morgan Stanley holds 75,769 shares of CMRX stock, worth $73,495. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,769

Previous 68,199 11.1%

Holding current value

$73,495

Previous $72,000 8.33%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	BUY	$0.87 - $1.05 $6,585 - $7,948	7,570 Added 11.1%	75,769 $66,000
Q2 2024 Aug 14, 2024	BUY	$0.87 - $1.05 $6,585 - $7,948	7,570 Added 11.1%	75,769 $66,000
Q1 2024 Oct 17, 2024	SELL	$0.91 - $1.26 $6,888 - $9,538	-7,570 Reduced 9.99%	68,199 $72,000
Q1 2024 Aug 16, 2024	SELL	$0.91 - $1.26 $287,073 - $397,485	-315,465 Reduced 82.22%	68,199 $72,000
Q1 2024 May 15, 2024	SELL	$0.91 - $1.26 $287,073 - $397,485	-315,465 Reduced 82.22%	68,199 $72,000
Q4 2023 Aug 16, 2024	BUY	$0.9 - $1.06 $277,105 - $326,368	307,895 Added 406.36%	383,664 $368,000
Q4 2023 Feb 13, 2024	SELL	$0.9 - $1.06 $269,720 - $317,670	-299,689 Reduced 43.86%	383,664 $368,000
Q3 2023 Nov 15, 2023	BUY	$0.94 - $1.23 $79,711 - $104,302	84,799 Added 14.17%	683,353 $656,000
Q2 2023 Aug 14, 2023	SELL	$1.1 - $1.54 $478,524 - $669,933	-435,022 Reduced 42.09%	598,554 $724,000
Q1 2023 May 15, 2023	BUY	$1.19 - $2.09 $308,924 - $542,564	259,600 Added 33.54%	1,033,576 $1.3 Million
Q4 2022 Feb 14, 2023	SELL	$1.67 - $2.35 $62,285 - $87,647	-37,297 Reduced 4.6%	773,976 $1.44 Million
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.76 $62,193 - $94,836	-34,361 Reduced 4.06%	811,273 $1.57 Million
Q2 2022 Oct 27, 2022	BUY	$1.34 - $5.34 $571,586 - $2.28 Million	426,557 Added 101.78%	845,634 $1.76 Million
Q2 2022 Aug 15, 2022	BUY	$1.34 - $5.34 $571,586 - $2.28 Million	426,557 Added 101.78%	845,634 $1.76 Million
Q1 2022 Oct 27, 2022	SELL	$4.58 - $6.8 $1.95 Million - $2.9 Million	-426,557 Reduced 50.44%	419,077 $1.92 Million
Q1 2022 May 13, 2022	BUY	$4.58 - $6.8 $1.1 Million - $1.63 Million	239,551 Added 133.44%	419,077 $1.92 Million
Q4 2021 Feb 14, 2022	BUY	$5.23 - $7.18 $265,391 - $364,341	50,744 Added 39.4%	179,526 $1.16 Million
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.75 $764,965 - $1.13 Million	128,782 New	128,782 $797,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account